These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2534286)

  • 1. [GnRH agonists in the ovulation stimulation scheme for in vitro fertilization].
    Roztocil A; Pilka L; Holubová M
    Cesk Gynekol; 1989 Dec; 54(10):776-82. PubMed ID: 2534286
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of gonadotropin releasing hormone agonists in ovulation induction.
    Dodson WC
    J Reprod Med; 1989 Jan; 34(1 Suppl):76-80. PubMed ID: 2497247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation concomitant with pituitary-ovarian axis suppression by different GnRH agonists.
    Insler V; Lunenfeld E; Potashnik G; Levy J
    Int J Fertil; 1991; 36(2):121-7. PubMed ID: 1674933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin releasing hormone agonists and the induction or augmentation of ovulation.
    Martin MC
    J Reprod Med; 1989 Dec; 34(12 Suppl):1034-8. PubMed ID: 2533619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Revisiting GnRH analog protocols II. Strategy for poor responders].
    Hugues JN; Cédrin-Durnerin I
    Contracept Fertil Sex; 1997 Sep; 25(9):717-24. PubMed ID: 9410395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there a role for GnRH analogs in ovulation stimulation for in vitro fertilization?].
    Belaisch-Allart J; Mayenga JM
    Contracept Fertil Sex; 1998 Nov; 26(11):761-3. PubMed ID: 9864882
    [No Abstract]   [Full Text] [Related]  

  • 9. GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Engmann L; Benadiva C
    Hum Reprod; 2005 Nov; 20(11):3258-60; author reply 3260. PubMed ID: 16246862
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
    Ashkenazi J; Goldman JA; Dicker D; Feldberg D; Goldman GA
    Fertil Steril; 1990 Apr; 53(4):738-40. PubMed ID: 2138573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gonadotropin releasing hormone agonists. A new therapeutic principle in gynecology].
    Tanbo T; Henriksen T; Magnus O; Abyholm T
    Tidsskr Nor Laegeforen; 1988 Jan; 108(2):132-5. PubMed ID: 2965433
    [No Abstract]   [Full Text] [Related]  

  • 12. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH analogues in the treatment of endometriosis.
    Erickson LD; Ory SJ
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between IVF and GIFT using the GnRH agonist protocol.
    Cittadini E; Palermo R; Agrifoglio V
    Acta Eur Fertil; 1988; 19(1):41-4. PubMed ID: 3137763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH antagonist in in vitro fertilization: where we are now.
    Shapiro DB; Mitchell-Leef D
    Minerva Ginecol; 2003 Oct; 55(5):373-88. PubMed ID: 14581880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of pulsatile gonadotropins and gonadotropin releasing hormone analogues for ovulation induction in chronic anovulatory patients].
    Bacchi Modena A; Vadora E; Fiaschetti D; Chiavazza F; Gramellini D
    Minerva Ginecol; 1988 Aug; 40(8):457-60. PubMed ID: 3063999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal stimulation in hyperandrogenemia patients in in-vitro fertilization].
    Fischl F; Müller-Tyl E; Bieglmayer C; Reinthaller A
    Gynakol Rundsch; 1991; 31 Suppl 2():74-8. PubMed ID: 1838738
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of GnRH agonists in the treatment of failed cycles in an IVF-ET program: a comparative study.
    Feldberg D; Goldman GA; Dicker D; Ashkenazi J; Yeshaya A; Goldman JA
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):103-9. PubMed ID: 2137420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.